Nathalie Gouge-Biebuyck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathalie Gouge-Biebuyck has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Armance Marchal
Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France
1 shared publication - Astrid Godron-Dubrasquet
Department of Pediatric Nephrology and Kidney Transplantation, Pellegrin Hospital, Bordeaux, France
1 shared publication - Baptiste Lamarthée
Université Marie et Louis Pasteur, Inserm UMR Right, Établissement Français du Sang, Besançon, France
1 shared publication - Brigitte Llanas
Department of Pediatric Nephrology and Kidney Transplantation, Pellegrin Hospital, Bordeaux, France
1 shared publication - Bruno Moulin
Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France
1 shared publication - Bénédicte Neven
Pediatric Immune-Hematology Unit, Necker Children Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
1 shared publication
Latest Publications
- Open Access
- 3 April 2024
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 17 (5) , sfae099
Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay
Primary hyperoxalurias (PH) are extremely rare genetic disorders characterized by clinical heterogeneity. Delay in diagnosing these conditions can have detrimental effects on patient outcomes. The primary objective of this study is to assess the current diagnostic delay for PH. This nationwide, observational and retrospective study included patients who received a genetic diagnosis of PH types 1, 2 and 3 between 1 January 2015 and 31 December 2019. Diagnostic delay was defined as the duration between the onset of symptoms and the time of genetic diagnosis. A total of 52 patients (34 children and 18 adults) were included in the study, with 40 PH1 (77%), 3 PH2 (6%) and 9 PH3 (17%). At the time of diagnosis, 12 patients (23%) required dialysis. Among the PH1 patients, the predominant symptom at onset in adults was renal colic (79% of cases), whereas symptoms in children were more diverse (renal colic in 17% of cases). The diagnostic delay was significantly shorter in children compared with adults [median (interquartile range)]: 1.2 (0.1–3.0) versus 30 (17–36) years, respectively (P < .0001). RNA interference was utilized in 23 patients (58%). Five individuals (13%) underwent double liver–kidney transplantation, and five (13%) received isolated kidney transplantation, with lumasiran therapy in four patients. For PH2 and PH3 patients, the diagnostic delay ranges from 0 to 3 years, with renal colic as first symptom in 33% of cases. This extensive and recent cohort of PH underscores the considerable delay in diagnosing PH, particularly in adults, even in a country with a dedicated organization for enhancing the overall management of rare diseases. These findings reinforce the imperative for increased awareness among relevant specialties regarding the evaluation of urolithiasis.
- 3 April 2024
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 17 (5) , sfae099
Open AccessPrimary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay
Primary hyperoxalurias (PH) are extremely rare genetic disorders characterized by clinical heterogeneity. Delay in diagnosing these conditions can have detrimental effects on patient outcomes. The primary objective of this study is to assess the current diagnostic delay for PH. This nationwide, observational and retrospective study included patients who received a genetic diagnosis of PH types 1, 2 and 3 between 1 January 2015 and 31 December 2019. Diagnostic delay was defined as the duration between the onset of symptoms and the time of genetic diagnosis. A total of 52 patients (34 children and 18 adults) were included in the study, with 40 PH1 (77%), 3 PH2 (6%) and 9 PH3 (17%). At the time of diagnosis, 12 patients (23%) required dialysis. Among the PH1 patients, the predominant symptom at onset in adults was renal colic (79% of cases), whereas symptoms in children were more diverse (renal colic in 17% of cases). The diagnostic delay was significantly shorter in children compared with adults [median (interquartile range)]: 1.2 (0.1–3.0) versus 30 (17–36) years, respectively (P < .0001). RNA interference was utilized in 23 patients (58%). Five individuals (13%) underwent double liver–kidney transplantation, and five (13%) received isolated kidney transplantation, with lumasiran therapy in four patients. For PH2 and PH3 patients, the diagnostic delay ranges from 0 to 3 years, with renal colic as first symptom in 33% of cases. This extensive and recent cohort of PH underscores the considerable delay in diagnosing PH, particularly in adults, even in a country with a dedicated organization for enhancing the overall management of rare diseases. These findings reinforce the imperative for increased awareness among relevant specialties regarding the evaluation of urolithiasis.
- Open Access
- 17 February 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (8) , 2243-2253
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation
- 17 February 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (8) , 2243-2253
Open AccessDonor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation